DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Kratochwil C, Giesel FL, Bruchertseifer F. et al.
(2)(1)(3)Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces
remission in neuroendocrine tumours refractory to beta radiation: a
first-in-human experience.
Eur J Nucl Med Mol Imaging 2014;
41: 2106-2119 doi:10.1007/s00259–014–2857–9
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.